Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Moms and babies get checked together: could group visits beat the standard?

NCT ID NCT07414901

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study looks at whether group visits for new mothers and their babies, instead of individual check-ups, can improve health for both. About 1,125 women and their infants in Malawi will take part. Researchers will measure things like mom's mood, baby's vaccines, and how connected moms feel to each other.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,125 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jan 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 week to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Aims 1\&2: * Women presenting for their 1-week postnatal care visit with their infant at a study site clinic. * Over age 15. * One infant is less than 4 weeks old. * Able to speak and understand Chichewa. * Adolescents 15-17 must bring parent/guardian for consent/assent. Infants included as part of mother-infant dyad. Aim 3: * Midwife or HSA serving as group care co-facilitator or key stakeholders in MoH/Zomba District/clinical administration * Able to speak Chichewa and/or English. Exclusion Criteria: Aim 1\&2 * Under age 15. * Serious physical or mental illness or marked cognitive impairment preventing informed consent. * Inability to participate in full intervention * Multiple infants (e.g. twins, triplets) Aim 3 -Serious physical or mental illness or marked cognitive impairment preventing informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bimbi HC

    NOT_YET_RECRUITING

    Zomba, Malawi

  • Chamba HC

    RECRUITING

    Zomba, Malawi

  • Chingale HC

    NOT_YET_RECRUITING

    Zomba, Malawi

  • Domasi HC

    NOT_YET_RECRUITING

    Zomba, Malawi

  • Lambulira HC

    RECRUITING

    Zomba, Malawi

  • Likangala HC

    RECRUITING

    Zomba, Malawi

  • M'mambo HC

    NOT_YET_RECRUITING

    Zomba, Malawi

  • Machinjiri HC

    RECRUITING

    Zomba, Malawi

  • Maera HC

    NOT_YET_RECRUITING

    Zomba, Malawi

  • Makwapala

    RECRUITING

    Zomba, Malawi

  • Matawale HC

    RECRUITING

    Zomba, Malawi

  • Mwandama HC

    NOT_YET_RECRUITING

    Zomba, Malawi

  • Naisi HC

    RECRUITING

    Zomba, Malawi

  • Namasalima HC

    RECRUITING

    Zomba, Malawi

  • Nasawa

    NOT_YET_RECRUITING

    Zomba, Malawi

  • Ngwelero HC

    NOT_YET_RECRUITING

    Zomba, Malawi

More trials for these conditions

Other studies related to the condition(s) this trial covers.